ESC TV Today – Your Cardiovascular News

In this enlightening discussion, J. Wouter Jukema, the Head of Cardiology at Leiden University Medical Center and an expert in LDL management, shares vital insights on cholesterol treatment strategies. He explores the intricate debate surrounding LDL cholesterol and reviews the efficacy of current therapies. Jukema emphasizes the benefits of statins while addressing common misconceptions and concerns. He also highlights the potential of combination therapies and the significance of lipoprotein little a in treating high-risk patients, paving the way for future advancements.

Carlos Aguiar, a cardiology expert known for summarizing key studies, joins the discussion to explore several cutting-edge topics. The coronary sinus reducer is highlighted as a promising solution for refractory angina, showcasing its innovative mechanisms and clinical trial results. Effective strategies for managing LDL cholesterol in high-risk patients are examined, stressing personalized treatment approaches. The insights into heart failure and atrial fibrillation reveal the importance of thorough diagnostic assessments and the impact of improved ejection fraction on outcomes.

Host: Rick Grobbee Guest: Steffen Petersen Want to watch that extended interview? Go to: https://esc365.escardio.org/event/1806?r Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Rick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

This episode covers: Cardiology This Week: A concise summary of recent studies The role of cardiac magnetic resonance in myocardial disease Air pollution and heart disease Statistics Made Easy: Quasi-experimental study designs Host: Rick Grobbee Guests: Carlos Aguiar, Steffen Petersen, Mark Miller Want to watch that episode? Go to: https://esc365.escardio.org/event/1806 Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Rick Grobbee, Nicolle Kraenkel and Mark Miller have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

In this intriguing discussion, Professor Michele Brignole, a distinguished expert on syncope from Italy, shares his insights on the evaluation and management of this puzzling condition. He highlights a standardized three-stage diagnostic approach and the importance of differentiating cardiac causes. The conversation dives into diagnostic strategies for unexplained syncope, emphasizing advanced monitoring techniques, especially for elderly patients. Listeners will learn about the significance of blood pressure variations and innovative methods like ambulatory monitoring.

Carlos Aguiar, a cardiologist who presents Cardiology This Week, delves into recent advances in cardiovascular care. He discusses the promising role of colchicine in preventing cardiovascular events, juxtaposed with recent trial findings. The conversation also explores the complexities of diagnosing syncope, especially in older adults, and emphasizes the importance of understanding its mechanisms for better treatment outcomes. Additionally, the Cybis II trial is highlighted for establishing beta blockers as vital therapy in chronic heart failure management.

Dive into the fascinating world of digital twins in cardiology! Discover the challenges of creating accurate computational models for heart health and how they can tackle clinical issues. Learn about personalized pacing strategies that adapt treatments to individual patient needs. Explore the integration of this cutting-edge technology into clinical workflows, and the essential considerations of cost, training, and ethics. Finally, uncover how digital twins could revolutionize precision medicine and transform patient care.

Carlos Aguiar, the host of Cardiology This Week, shares his insights on managing hypertension in elderly patients. He discusses tailored treatment strategies, emphasizing the importance of biological age and health status. The conversation shifts to innovative digital twin technology, revealing how it can personalize diagnostics and improve outcomes in cardiovascular care. Topics also include findings on the TAPI trial for acute heart failure and updated blood pressure guidelines to enhance the quality of life in older adults.

This episode covers: Cardiology This Week: A concise summary of recent studies Current indications for pulmonary vein isolation Conduction system pacing EHRA 2025 scientific highlights Host: Susanna Price Guests: Haran Burri, Isabel Deisenhofer, Helmut Puererfellner, Emma Svennberg Want to watch that episode? Go to: https://esc365.escardio.org/event/1803   Disclaimer ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.   Declarations of interests Stephan Achenbach, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Haran Burri has declared to have potential conflicts of interest to report: institutional research and fellowship support or speaker honoraria from Abbott, Biotronik, Boston Scientific, Medtronic, Microport. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Isabel Deisenhofer has declared to have potential conflicts of interest to report: speaker honoraria and travel grants from Abbott Medical, Biosense-Webster, Boston Scientific, BMS, Volta Medical, and research grant (for the institution) from Abbott Medical and Daiichi Sankyo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Helmut Puererfellner has declared to have potential conflicts of interest to report: speaker fees, honoraria, consultancy, advisory board fees, investigator, committee member, etc., including travel funding related to these activities for the following companies: Abbott, Biotronik, Biosense Webster, Boston Scientific, Daiichi Sankyo, Medtronic. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

In this enlightening conversation, Professor Thomas Deneke, a leading expert in ventricular ectopy, shares his insights on managing ventricular ectopic beats. He discusses the critical connection between left ventricular function and premature ventricular contractions, stressing the importance of monitoring these beats in patients with heart conditions. Deneke also explores treatment options, including the role of exercise testing, beta blockers, and catheter ablation, especially for those recovering from heart attacks, emphasizing personalized care for optimal outcomes.